Cass, This is certainly no threat to BrachySil which is to be PSD's main source of revenue in the coming years. TDS appears to be just an improvement on existing transdermal patches. IMO nothing has been demonstrated from this that would compete with PSDs proposed products. However, you cant rule this out. Like psd, they are interested in developing delivery methods that potentially could extend patent life of drugs. 10 years from now, who knows!
- Forums
- ASX - By Stock
- PSD
- tds technology
PSD
psivida limited
tds technology, page-2
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PSD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online